Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Decision making about medications in rheumatoid arthritis

Shaw, Yomei (2017) Decision making about medications in rheumatoid arthritis. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

[img] PDF
Submitted Version
Restricted to University of Pittsburgh users only until December 2021.

Download (779kB) | Request a Copy

Abstract

Understanding the issues surrounding decision making about medication treatments has important implications for public health, including improving the quality of care for patients with chronic conditions. This dissertation examines medication decisions in one chronic condition, rheumatoid arthritis (RA).

Chapter one introduces the context of decision making about medications in RA. Guidelines recommend treating RA to the target (T2T) of low disease activity (LDAS) with disease-modifying antirheumatic drugs (DMARDs). T2T requires regularly monitoring for moderate/high disease activity (MHDAS), and adjusting DMARDs at least every 3 months until the patient reaches LDAS. The chapter provides background on the challenges of implementing T2T, and summarizes chapters two through four.

Chapter two addresses delays in DMARD adjustment for patients with MHDAS. Survival analysis is used to examine the extent of delays in DMARD adjustments and whether delayed DMARD adjustment leads to delayed LDAS. Forty percent of RA patients with persistent MHDAS wait longer than 3 months to receive DMARD adjustment, and timely DMARD adjustment is associated with reaching LDAS sooner. There may be a need to reduce delays in DMARD therapy adjustment for many patients.

Chapter three examines patients’ perspectives on medication decisions, exploring how feelings in response to events and information motivate decisions to accept or resist medications. Patients’ feelings towards the benefits and dangers of medications, their identity as an ill person, the act of taking medication, and the decision process itself affect willingness to accept medications. Awareness of feelings motivating resistance to taking medications may allow physicians to better support patients confronting threatening information and difficult treatment decisions.

Chapter four compares patient joint assessments with physician joint assessments to examine their suitability for disease activity monitoring between visits. Although agreement on joint assessment items is modest, agreement on detection of MHDAS is better. Patient joint assessments may be useful for disease monitoring between visits, potentially reducing delays to DMARD adjustment.

This dissertation provides a multi-level view of treatment guideline implementation in RA. Understanding the interdependency of patient, provider, and system level factors in medication decisions is valuable for improving the quality of care for patients with chronic conditions.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: University of Pittsburgh ETD
Status: Unpublished
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Shaw, Yomeiyos22@pitt.eduYOS220000-0001-7048-8687
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairRoberts, Mark S.mroberts@pitt.eduMROBERTS
Committee MemberDonohue, Julie M.jdonohue@pitt.eduJDONOHUE
Committee MemberChang, Chung-Chou H.changjh@upmc.eduCHANGJ
Committee MemberChang, Judy C.chanjc@mail.magee.edu
Committee MemberMichaud, Kalebkalebm@gmail.com
Date: 24 February 2017
Date Type: Publication
Defense Date: 24 August 2016
Approval Date: 24 February 2017
Submission Date: 8 November 2016
Access Restriction: 5 year -- Restrict access to University of Pittsburgh for a period of 5 years.
Number of Pages: 162
Institution: University of Pittsburgh
Schools and Programs: Graduate School of Public Health > Health Policy & Management
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: rheumatoid arthritis, decision, medication, disease-modifying antirheumatic drug, treat to target, patient, qualitative, survival analysis, disease monitoring
Date Deposited: 24 Feb 2017 19:23
Last Modified: 24 Feb 2017 19:23
URI: http://d-scholarship.pitt.edu/id/eprint/30239

Metrics

Monthly Views for the past 3 years

Plum Analytics


Actions (login required)

View Item View Item